A detailed history of Douglas Lane & Associates, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Douglas Lane & Associates, LLC holds 592,860 shares of JNJ stock, worth $90.8 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares
592,860
Previous 577,352 2.69%
Holding current value
$90.8 Million
Previous $84.4 Million 13.86%
% of portfolio
1.35%
Previous 1.22%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$145.48 - $167.38 $2.26 Million - $2.6 Million
15,508 Added 2.69%
592,860 $96.1 Million
Q2 2024

Jul 08, 2024

BUY
$144.38 - $157.78 $4.63 Million - $5.06 Million
32,098 Added 5.89%
577,352 $84.4 Million
Q1 2024

Apr 11, 2024

BUY
$155.22 - $162.74 $3.83 Million - $4.02 Million
24,686 Added 4.74%
545,254 $86.3 Million
Q4 2023

Jan 17, 2024

BUY
$145.6 - $158.88 $5.88 Million - $6.41 Million
40,363 Added 8.41%
520,568 $81.6 Million
Q3 2023

Oct 16, 2023

BUY
$155.75 - $174.48 $5.2 Million - $5.83 Million
33,412 Added 7.48%
480,205 $74.8 Million
Q2 2023

Jul 19, 2023

BUY
$154.35 - $166.11 $5.27 Million - $5.67 Million
34,122 Added 8.27%
446,793 $74 Million
Q1 2023

Apr 17, 2023

BUY
$151.05 - $180.26 $2.44 Million - $2.92 Million
16,174 Added 4.08%
412,671 $64 Million
Q4 2022

Feb 14, 2023

SELL
$160.2 - $179.79 $192,400 - $215,927
-1,201 Reduced 0.3%
396,497 $70 Million
Q4 2022

Jan 17, 2023

BUY
$160.2 - $179.79 $6 Million - $6.74 Million
37,478 Added 10.4%
397,698 $70.3 Million
Q3 2022

Oct 14, 2022

BUY
$161.33 - $179.52 $543,520 - $604,802
3,369 Added 0.94%
360,220 $58.8 Million
Q2 2022

Jul 18, 2022

BUY
$168.19 - $186.01 $1.28 Million - $1.42 Million
7,638 Added 2.19%
356,851 $63.3 Million
Q1 2022

Apr 25, 2022

BUY
$158.14 - $179.59 $5.88 Million - $6.68 Million
37,212 Added 11.93%
349,213 $61.9 Million
Q4 2021

Jan 25, 2022

BUY
$155.93 - $173.01 $7.55 Million - $8.38 Million
48,438 Added 18.38%
312,001 $53.4 Million
Q3 2021

Oct 21, 2021

BUY
$161.5 - $179.47 $3.8 Million - $4.23 Million
23,548 Added 9.81%
263,563 $42.6 Million
Q2 2021

Jul 19, 2021

BUY
$159.48 - $171.07 $3.47 Million - $3.72 Million
21,764 Added 9.97%
240,015 $39.5 Million
Q1 2021

Apr 19, 2021

BUY
$153.07 - $170.48 $3.56 Million - $3.96 Million
23,243 Added 11.92%
218,251 $35.9 Million
Q4 2020

Jan 14, 2021

BUY
$137.11 - $157.38 $5.46 Million - $6.27 Million
39,822 Added 25.66%
195,008 $30.7 Million
Q3 2020

Oct 19, 2020

BUY
$140.38 - $153.83 $1.12 Million - $1.23 Million
7,966 Added 5.41%
155,186 $23.1 Million
Q2 2020

Jul 28, 2020

BUY
$128.81 - $155.51 $2.95 Million - $3.56 Million
22,898 Added 18.42%
147,220 $20.7 Million
Q1 2020

Apr 20, 2020

BUY
$111.14 - $153.99 $6.52 Million - $9.04 Million
58,700 Added 89.45%
124,322 $16.3 Million
Q4 2019

Jan 27, 2020

BUY
$127.5 - $146.44 $142,417 - $163,573
1,117 Added 1.73%
65,622 $9.57 Million
Q3 2019

Oct 16, 2019

BUY
$126.95 - $142.14 $51,668 - $57,850
407 Added 0.63%
64,505 $8.35 Million
Q2 2019

Jul 08, 2019

SELL
$131.15 - $144.24 $207,348 - $228,043
-1,581 Reduced 2.41%
64,098 $8.93 Million
Q1 2019

Apr 23, 2019

BUY
$125.72 - $139.79 $50,916 - $56,614
405 Added 0.62%
65,679 $9.18 Million
Q4 2018

Jan 17, 2019

SELL
$122.84 - $147.84 $358,815 - $431,840
-2,921 Reduced 4.28%
65,274 $8.42 Million
Q3 2018

Oct 09, 2018

SELL
$121.58 - $142.88 $67,841 - $79,727
-558 Reduced 0.81%
68,195 $9.42 Million
Q2 2018

Jul 23, 2018

SELL
$119.4 - $131.76 $221,248 - $244,151
-1,853 Reduced 2.62%
68,753 $8.34 Million
Q1 2018

Apr 23, 2018

SELL
$125.1 - $148.14 $338,895 - $401,311
-2,709 Reduced 3.7%
70,606 $9.05 Million
Q4 2017

Jan 24, 2018

SELL
$131.22 - $143.62 $959,874 - $1.05 Million
-7,315 Reduced 9.07%
73,315 $10.2 Million
Q3 2017

Oct 19, 2017

BUY
$129.47 - $135.38 $10.4 Million - $10.9 Million
80,630
80,630 $10.5 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $400B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Douglas Lane & Associates, LLC Portfolio

Follow Douglas Lane & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglas Lane & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglas Lane & Associates, LLC with notifications on news.